InsidersTradesSigma
BioPorto A/S: directors' dealings · Denmark · Finanstilsynet DK
DK:bioporto-asDK0011048619DK·Finanstilsynet DKMcap 604M€Healthcare
Explore the full directors' dealings record of BioPorto A/S, a listed issuer based in Denmark. Shares are listed on DK DK, under the oversight of Finanstilsynet DK. Operating in the Healthcare sector, BioPorto A/S has logged 30 public disclosures. Market capitalisation: €604m. The latest transaction was reported on 24 November 2025 — Subscription. Among the most active insiders: Unknown. The full history is openly available.
30
Insider Decl.
0
Thresholds
€30m
6 ops.
Buy Volume
€3m
1 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
1.22 €
Analyst consensus
1 analysts1.75 €Target 1.75 €(+43%)1.75 €
Income statement
Revenue40.3 M€
Gross profit30.4 M€75% margin
Net income−82.1 M€-203.8% margin
Valuation
PER (forward)-17.4x
P/Book9.6x
Beta1.28
Balance sheet & cash
Market cap604.0 M€
Total debt7.5 M€
Free Cash Flow−77.1 M€
Debt / Equity12%
Profitability & ownership
ROE-125.6%
ROA-51.8%
% insiders29.8%
% institutions6.2%
Last declaration on 24 November 2025
Declarations0 total
No declarations found
0 of 0 declarations
About BioPorto A/S
BioPorto A/S is a Danish company specializing in the development of medical diagnostics. It focuses on innovative tests for serious diseases, particularly kidney disorders.